Track topics on Twitter Track topics that are important to you
9640 Medical Center Drive
United States of America
Fax: (301) 315-2438
SummaryCytImmune Sciences Inc CytImmune is a clinical stage nanomedicine company that discovers, develops, and commercializes tumortargeted therapies. The company develops nanotherapy platform, Aurimu...
SummaryCytImmune Sciences Inc CytImmune is a clinical stage nanomedicine company that discovers, develops, and commercializes tumortargeted therapies for the treatment of cancer. The company develops ...
CytImmune is focused on the chemistry for colloital gold for drug/gene delivery in the treatment of cancer, while concentrating on the development of patented cytokine and angiogenic immunoassay kits ...
CytImmune is a clinical stage biopharmaceutical based in Rockville, MD. The Company is developing a pipeline of multifunctional, next-generation therapeutics, binding known anti-cancer agents – who...
We have published hundreds of CytImmune news stories on BioPortfolio along with dozens of CytImmune Clinical Trials and PubMed Articles about CytImmune for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CytImmune Companies in our database. You can also find out about relevant CytImmune Drugs and Medications on this site too.
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...
Nanotechnology is the engineering of functional systems at the molecular scale. This covers both current work and concepts that are more advanced. In its original sense, 'nanotechnology' refers to the projected ability to construct items fr...